DaVita Inc. logo

DaVita Inc. (DVA)

Market Closed
22 Jul, 20:00
NYSE NYSE
$
232. 08
-5.2
-2.1915%
$
15.21B Market Cap
16.41 P/E Ratio
- Div Yield
979,361 Volume
7.83 Eps
$ 237.28
Previous Close
Add Transaction
Day Range
230.35 237.11
Year Range
101 239.64
Want to track DVA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
5 Stocks to Gain as Service Side of the Economy Bounces Back

5 Stocks to Gain as Service Side of the Economy Bounces Back

With service sector activity rebounding in recent times, it's worth placing bets on stocks such as CareCloud (CCLD), DaVita (DVA), RadNet (RDNT), SkyWest (SKYW) and American Express (AXP).

Zacks | 2 years ago
DaVita (DVA), Nuwellis Extend Pilot Collaboration for Aquadex

DaVita (DVA), Nuwellis Extend Pilot Collaboration for Aquadex

DaVita (DVA) extends its pilot collaboration with Nuwellis to conduct additional testing of the Aquadex ultrafiltration treatment for adult patients suffering from congestive heart failure and related conditions.

Zacks | 2 years ago
Here's Why DaVita HealthCare (DVA) is a Strong Momentum Stock

Here's Why DaVita HealthCare (DVA) is a Strong Momentum Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 2 years ago
Is DaVita (DVA) Stock Outpacing Its Medical Peers This Year?

Is DaVita (DVA) Stock Outpacing Its Medical Peers This Year?

Here is how DaVita HealthCare (DVA) and Twist Bioscience (TWST) have performed compared to their sector so far this year.

Zacks | 2 years ago
DaVita HealthCare (DVA) Sees a More Significant Dip Than Broader Market: Some Facts to Know

DaVita HealthCare (DVA) Sees a More Significant Dip Than Broader Market: Some Facts to Know

The latest trading day saw DaVita HealthCare (DVA) settling at $143.18, representing a -0.46% change from its previous close.

Zacks | 2 years ago
Are Investors Undervaluing DaVita (DVA) Right Now?

Are Investors Undervaluing DaVita (DVA) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks | 2 years ago
DaVita (DVA) Hits 52-Week High: What's Aiding the Stock?

DaVita (DVA) Hits 52-Week High: What's Aiding the Stock?

Investors are optimistic about DaVita's (DVA) strength in kidney care.

Zacks | 2 years ago
DaVita Inc. (DVA) Hit a 52 Week High, Can the Run Continue?

DaVita Inc. (DVA) Hit a 52 Week High, Can the Run Continue?

DaVita HealthCare (DVA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Zacks | 2 years ago
Why DaVita HealthCare (DVA) is a Top Momentum Stock for the Long-Term

Why DaVita HealthCare (DVA) is a Top Momentum Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 2 years ago
Is DaVita (DVA) Stock Undervalued Right Now?

Is DaVita (DVA) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks | 2 years ago
DaVita (DVA) Gains 34.5% YTD: What's Driving the Stock?

DaVita (DVA) Gains 34.5% YTD: What's Driving the Stock?

DaVita's (DVA) shares gain on the back of strong fundamentals. However, dependence on commercial payers can be a cause of concern.

Zacks | 2 years ago